Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine pretreatment to reduce etomidate-induced myoclonus in gastroscopy
ChiCTR2500103005Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in myoclonus (3 arms), sponsored by First Affiliated Hospital of Xiamen University. Primary endpoint: Myoclonus incidence and severity. Planned start May 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
myoclonus
Beyond the preview
Go deeper on ChiCTR2500103005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103005.